Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Cirtec makes Nuvectra neuromod device info available to customers

February 2, 2021 By Nancy Crotti

The Algovita spinal cord stimulation system, which Cirtec Medical bought from Nuvectra in 2020 (Image from Nuvectra)

Cirtec Medical is making proprietary information about a neuromodulation device — purchased from bankrupt Nuvectra — available to customers seeking regulatory approval for similar devices.

The decision, announced Monday, involved Cirtec withdrawing the FDA premarket approval for the Nuvectra Algovita spinal cord stimulation system and converting that information into a master file housed at the FDA. This allows Cirtec to give its customers access to the Algovita information so they can use it to develop new technologies. For example, if a startup that has a development agreement with Cirtec wants to run a preclinical or clinical trial based on the Algovita technology, that startup can cite the past studies in the master file in its submission for an FDA investigational device exemption application, Cirtec CEO Brian Highley told Medical Design & Outsourcing.

Cirtec bought Algovita to add it to its Simplifi neuromodulation R&D platform than to commercialize Algovita directly. As a contract manufacturer, Cirtec is not in a position to do postmarket surveillance, Highley said. It also sells components of the system.

“Very basically, we can take the device and sell off-the-shelf components under this master file and get them in the hands of one of our customers quickly,” Highley said. “It’s also customizable, so if you need a smaller device or different configurations, we can easily modify the system for them.”

Several customers who are interested in the technology can now reference the FDA master file with Cirtec’s permission.

Plano, Texas-based Nuvectra filed for Chapter 11 bankruptcy protection in November 2019 and Cirtec bought the Algovita intellectual property and certain assets from Nuvectra in May 2020. Cirtec was not among Nuvectra’s creditors, Highley noted. Two contract manufacturers with unsecured claims were Minnetronix Medical and Greatbatch Medical, now a part of Integer Holdings (NYSE:ITGR). Minnetronix was owed nearly $2.8 million, and Greatbatch’s unsecured claim was nearly $2.2 million.

Nuvectra began as the QiG Group, a part of Greatbatch Medical before its spinout was approved in February 2016. But its Algovita device was up against stiff competition in the SCS space, which is dominated by much larger companies — Abbott, Boston Scientific, Medtronic and Nevro.

“There’s a lot of innovation going on in neuromodulation, but in order for a startup or somebody in academia to get something to market quickly, they’d have to go to Medtronic, Boston or Abbott,” Highley said. “These guys don’t like to deal with some of the small startups. We were looking for a way of supporting the neuromodulation community and providing an option to get a product in a customer’s hand quickly.”

Cirtec’s PMA-to-master-file conversion, which it undertook on the FDA’s advice, is not common, but contract manufacturers have done it before, according to longtime medtech consultant Mark Bonifacio.

“That’s a great strategy for the CM, and you’ve really got what you wanted if they get the 510(k) approval or the PMA,” Bonifacio said in an interview with MDO. “It’s not uber-common but it’s definitely not weird or it’s not out of the jurisdiction of the FDA to say this. … I think it’s a good suggestion for Brian and the folks at Cirtec to go down that route.”

Cirtec’s move has also drawn praise from others.

“Translating neuromodulation research concepts in academia just became much easier,” said University of Minnesota Medical School professor Greg Molnar in a news release. “Having access to Cirtec’s Simplifi clinical neurostimulation system and master file can be leveraged to support physician-sponsored IDE studies that would otherwise not be possible.”

“Leveraging Cirtec’s Simplifi neuromodulation platform has enabled Comphya to significantly reduce our cost and time to market by leveraging the existing validation reports and other objective evidence rather than creating our own,” added Cirtec customer Rodrigo Fraga, CEO of Comphya.

Related Articles Read More >

Big 100: Steris logo - Largest Medical Device Companies
Steris discloses pay for top executives and its median employee
An illustration of the Endogenex ReCET system inside a patient.
This minimally invasive diabetes device delivers pulsed field energy in the gut
A photo of Steri-Tek CEO Larry Nichols and IBA Deputy CEO Henri de Romrée
Steri-Tek plans sterilization capacity expansion with IBA X-ray irradiation
An image of an infusion pump.
Cybersecurity report flags device vulnerabilities and user needs
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe